Harter Secrest & Emery LLP, a full-service business law firm with offices throughout New York, recently represented Maxim Group in an underwritten public offering of shares of common stock and warrants of Milestone Scientific, raising total gross proceeds of approximately $4.7 million (before underwriting discounts, commissions and estimated offering expenses). The HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Kayla E. Klos, and Kevin R. Pregent.
Maxim Group, a leading full-service investment banking, securities and wealth management firm headquartered in New York, NY, provides a full array of financial services to a diverse range of corporate clients, institutional investors, and high net worth individuals.
Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems such as the DPS Dynamic Pressure Sensing Technology are designed to make injections precise, efficient, and virtually painless.
Harter Secrest & Emery is recognized within Upstate New York as a leader in the securities and capital markets industry. The firm has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. The firm’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, and securities litigation and arbitration before the Securities and Exchange Commission, self-regulatory organizations, and state and federal courts.
For more information on Maxim Group, please click here.